[Pharmacy clinics. How I treat...arthritis. First part: pathophysiologic recurrence and symptomatic treatment].
Osteoarthritis is now considered in all developed countries as a major burden for public health. During several years, the pharmacological management of osteoarthritis mainly focused on symptoms relief without interaction with the long-term structural progression of this disease. Based on recently published consensus, the present article summarizes the currently available options in the symptom-modifying management of osteoarthritis.
Reginster
J Y
JY
Service de Santé Publique et d'Epidémiologie, Université de Liège.
Henrotin
Y
Y
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D010166:Palliative Care; D012008:Recurrence; D012720:Severity of Illness Index
D000894:Anti-Inflammatory Agents, Non-Steroidal